Concepedia

Evelyne Dietrich

ED

Statistics

Publications

14

Citations

848

H-Index

13

Active since

2003

Affiliations

Washington University in St. Louis(Current)

Lunenfeld-Tanenbaum Research Institute

University of Toronto

Mount Sinai Hospital

Aegera Therapeutics (Canada)

Evelyne Dietrich is an author at Washington University in St. Louis specializing in medicinal chemistry, pharmacology, and life sciences.

ORCID

Publications per year

2003–2022

14

Publications

14

CCNE1 amplification is synthetic lethal with PKMYT1 kinase inhibition

David Gallo, Jordan T.F. Young, Jimmy Fourtounis et al. · Nature · 2022 · 229 citations · Full text

, , +17

Oritavancin Exhibits Dual Mode of Action to Inhibit Cell-Wall Biosynthesis in Staphylococcus aureus

Sung Joon Kim, Lynette Cegelski, Dirk Stueber et al. · Journal of Molecular Biology · 2008 · 131 citations · Full text

, , +13

Vancomycin and Oritavancin Have Different Modes of Action in Enterococcus faecium

Gary J. Patti, Sung Joon Kim, Tsyr‐Yan Yu et al. · Journal of Molecular Biology · 2009 · 79 citations · Full text

, , +13

Linking Bisphosphonates to the Free Amino Groups in Fluoroquinolones: Preparation of Osteotropic Prodrugs for the Prevention of Osteomyelitis

Tom J. Houghton, Kelly S.E. Tanaka, Ting Kang et al. · Journal of Medicinal Chemistry · 2008 · 74 citations

, , +15

Discovery of an Orally Bioavailable and Selective PKMYT1 Inhibitor, RP-6306

Janek Szychowski, Robert Papp, Evelyne Dietrich et al. · Journal of Medicinal Chemistry · 2022 · 72 citations · Full text

, , +14

1–5 of 14